Case Reports in Endocrinology (Jan 2018)
Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature
Abstract
Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.